LEVOSS
The most common treatment of bone defects involves the use of autograft suffering from co-morbidity and the need for two operations. Others include allografts and alloplastics, but none have succesfully built longterm functional bone in vivo. Current treatment options for severe articular cartilage injuries are expensive, lengthy, palliative in nature, and result in generation of fibrous cartilage, which is ill adapted to the mechanical forces within a large joint, such as the knee. The LevOss scaffolds for bone and cartilage target a clearly defined market for spinal fusion surgery and for grade III/IV cartilage injuries with an increasing demand for better solutions and few competitors.
LEVOSS
Industry:
Biotechnology Health Care Medical Device
Founded:
2011-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.levoss.com
Total Employee:
1+
Status:
Active
Contact:
(452)194-7856
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Bodis DNS
Similar Organizations
Arterius
Arterius developing a novel next-generation polymer-based Bio-resorbable Coronary Scaffold (BRS), more commonly known as a ‘stent’.
Current Employees Featured
Founder
Investors List
Seed Capital
Seed Capital investment in Venture Round - LevOss
Official Site Inspections
http://www.levoss.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
